Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALPMY | TAK | NBIX | ||
| Company | Astellas Pharma Inc | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | ||
| Open | 10.1200 | 13.40 | 146.23 | ||
| High | 10.3500 | 13.57 | 148.88 | ||
| Low | 10.1200 | 13.40 | 146.23 | ||
| Last | 10.3500 | 13.53 | 147.23 | ||
| Change | +0.0100 | +0.17 | +1.54 | ||
| % Change | +0.10% | +1.27% | +1.06% | ||
| Volume | 423 | 246,965 | 52,083 | ||
| 20-Day Average Volume | 185,166 | 1,702,537 | 679,828 | ||
| Previous Close | 10.3400 | 13.36 | 145.69 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.1189 | 13.21 | 141.75 | ||
| 20-Day Raw Stochastic | 67.44% | 80.00% | 83.88% | ||
| 20-Day Relative Strength | 57.50% | 56.62% | 61.16% | ||
| Weighted Alpha | -26.59 | -10.24 | +41.37 | ||
| Today's Opinion | 24% Sell | 24% Sell | 100% Buy | ||
| Previous Opinion | 24% Sell | 56% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 100% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.67% since 07/15/24 | +1.23% since 07/15/24 | +0.04% since 07/15/24 | ||
| Low | 10.0400 on 07/16/24 | 13.24 on 07/19/24 | 143.09 on 07/19/24 | ||
| High | 10.7700 on 07/18/24 | 13.75 on 07/17/24 | 150.39 on 07/16/24 | ||
| 1-Month | |||||
| %Chg | +8.72% since 06/21/24 | +7.58% since 06/21/24 | +9.63% since 06/21/24 | ||
| Low | 9.4800 on 06/24/24 | 12.77 on 06/24/24 | 132.62 on 06/26/24 | ||
| High | 10.7700 on 07/18/24 | 13.75 on 07/17/24 | 150.39 on 07/16/24 | ||
| 3-Month | |||||
| %Chg | +8.60% since 04/22/24 | +1.46% since 04/22/24 | +10.37% since 04/22/24 | ||
| Low | 9.3500 on 06/20/24 | 12.57 on 06/20/24 | 129.33 on 06/20/24 | ||
| High | 10.7700 on 07/18/24 | 13.75 on 07/17/24 | 150.39 on 07/16/24 | ||
| 6-Month | |||||
| %Chg | -10.54% since 01/22/24 | -8.35% since 01/22/24 | +5.53% since 01/22/24 | ||
| Low | 9.1500 on 04/16/24 | 12.57 on 06/20/24 | 128.00 on 02/07/24 | ||
| High | 11.8840 on 02/01/24 | 14.88 on 02/27/24 | 150.39 on 07/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,711,916 | 42,282,220 | 14,661,805 | ||
| Shares Outstanding, K | 1,809,663 | 3,164,837 | 100,637 | ||
| Annual Sales | 11,108,100,000 | 29,419,960,000 | 1,887,100,000 | ||
| Annual Net Income | 118,070,000 | 994,060,000 | 249,700,000 | ||
| Last Quarter Sales | 2,793,590,000 | 6,938,670,000 | 515,300,000 | ||
| Last Quarter Net Income | -224,230,000 | -46,010,000 | 43,400,000 | ||
| 60-Month Beta | 0.38 | 0.54 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.11 on 04/25/24 | 0.00 on 05/09/24 | 0.42 on 05/01/24 | ||
| Latest Earnings Date | 08/06/24 | 07/31/24 | 08/01/24 | ||
| Most Recent Dividend | 0.152 on 03/26/24 | 0.261 on 09/28/23 | N/A | ||
| Next Ex-Dividends Date | 03/26/24 | 03/27/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 30.29 | 8.65 | 39.71 | ||